A2 Biotherapeutics Revenue and Competitors

Agoura Hills,

Location

$128.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • A2 Biotherapeutics's estimated annual revenue is currently $32.4M per year.(i)
  • A2 Biotherapeutics's estimated revenue per employee is $193,750
  • A2 Biotherapeutics's total funding is $128.5M.

Employee Data

  • A2 Biotherapeutics has 167 Employees.(i)
  • A2 Biotherapeutics grew their employee count by 1% last year.

A2 Biotherapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
President and CEOReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
VP, Head Technical OperationsReveal Email/Phone
5
VP Discovery ResearchReveal Email/Phone
6
VP, Head Regulatory AffairsReveal Email/Phone
7
Scientific DirectorReveal Email/Phone
8
Director, Head Manufacturing OperationsReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Clinical Development Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is A2 Biotherapeutics?

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and raised a Series A financing of $57 million (The Column Group, Vida Ventures, Samsara Capital and Nextech Invest).

keywords:N/A

$128.5M

Total Funding

167

Number of Employees

$32.4M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

A2 Biotherapeutics News

2022-03-30 - Geneos Therapeutics Raises $17M in Series A2 Funding

Geneos Therapeutics, a Plymouth Meeting, PA- based clinical stage biotherapeutics company, raised $17M in Series A2 funding.

2022-03-22 - Geneos Therapeutics Secures $17 Million in Series A2 ...

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform · Geneos expands its Phase...

2022-03-22 - A2 Bio publishes key preclinical findings demonstrating ...

("A2 Bio''), a biotechnology company focused on the treatment of solid tumors, announced today that key preclinical data related to its...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$46.3M1674%$8.2M
#2
$50.5M20112%N/A
#3
$66.8M2253%N/A
#4
$51.8M2699%N/A
#5
$78.4M3074%N/A